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3D-Human Tissue Chips Fabricated by Inkjet Cell Printing 
Michiya MA TSUSAKI* and Mitsuru AKASHI* 
(Received Sep. 10, 2012) 
We demonstrate a LbL assembly using the inkjet printing of single cells and proteins to enable the fabrication 
of 3D human micro-tissue arrays, which are integrated structures of micrometer-sized cellular multilayers 
controlled at the single-cell layer level, for application of pharmaceutical assays. Introduction of automatic inkjet 
printing of cells and proteins must be necessary for giving an assurance of their reproducibility. The 440 micro-
arrays which were the integration of simplified and multilayered liver structures were successfully developed 
and comprehensive high-throughput assays of liver functions were performed. We found for the first time that 
these simplified 3D liver structures, a sandwich of endothelial cells and hepatocytes, revealed the highest 
functions as compared to other 3D-structures. These 3D-human tissue chips would enable the "total-human 
tissue models" for tailor-made drug screening. 
Keywords: Inkjet printing, Cells, Human tissue chip, Pharmaceutical assay 
1. Introduction 
In vitro human cell-based drug evaluations, including drug 
efficacy testing, toxicology, and basic cell biology, 1.2) are of 
great importance as an alternative method to animal experi-
ments to solve the significant issue of species differences. In 
particular, animal testing for cosmetics and chemicals will be 
prohibited under the 7th Amendment to the Cosmetics 
Directive (Council Directive 761768/EEC) and REACH 
(registration, evaluation, authorization and restriction of 
chemicals) in the European Union (EU). Cell-based drug 
evaluations have been performed on a plastic dish at monolayer 
(two-dimensional: 2D) cell conditions. Since nearly all tissues 
are integrated three-dimensional (3D) structures of multiple 
types of cells and extracellular matrices (ECMs), and since 
intercellular signalling is important for tissue functions, it is 
generally difficult to evaluate actual tissue functions by 2D-
culture methods. Furthermore, high-throughput assays of 
human tissue responses using micro-arrays are valuable for 
the rapid assessment of drugs, chemicals and cosmetics. 
Accordingly, the development of 3D human tissue chips 
consisting of simplified tissue structures with multiple types of 
cells and ECMs is a key challenge for pharmaceutical 
evaluations. 
To date, photopolymerized gels with 3D micro-organized 
cells, 3) miniaturized multi-well culture systems·) and poly-
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meric aqueous two-phase systemsS) have been reported for the 
fabrication of micro-patterned heterocellular structures. 
Although these methods are intriguing, they face limitations 
both in terms of impaired cell-cell contact due to gel 
encapsulation and in the 3D control of cell positioning at the 
single-cell level. The 3D human micro-tissue chips composed 
of precisely-controlled 3D structures and cell types have not 
yet been available. 
Here, we demonstrate a Layer-by-Layer (LbL) assembly ill 
using the inkjet printing of single cells and proteins to enable 
the fabrication of 3D human micro-tissue arrays, which are 
integrated structures of micrometer-sized cellular multilayers 
controlled at the single-cell layer level. Inkjet printing is a 
promising technology for non-contact and computer-aided 
design (CAD) cell printing,7) and thus the printing cell 
number can be controlled at the single-cell level. Challenging 
research to develop 3D tissue or organ structures have been 
reported by cell, protein, or polymer printing,s.9) but these 
approaches all face the issues of impaired cell-cell contact due 
to gel or polymer encapsulation, We recently reported a simple 
and unique bottom-up approach, termed "hierarchical cell 
manipulation", to develop 3D cellular multilayers with the 
desired layer number and location by the fabrication of 
nanometer-sized LbL fibronectin (FN)-gelatin (G) (FN-G) 
films as a nano-ECM onto the cell surfaces, 10-12) Since FN is one 
of the most important cell adhesive ECMs, 131 nanometer-sized 
FN-G thin films can act as a stable adhesive surface for the 
adhesion of the second cell layer and promote cell-cell 
interactions without cytotoxicity. For example, five-layered 
(5L) constructs like a blood vessel wall structure fabricated 
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Fig. 1 a) Schematic illustration of the development of 3D micro-tissue arrays by the LbL printing of 
single cells and proteins. b) Fluorescence merged image of lL to 5L-spots prepared by the LbL 
printing of 0.2 mg ml- 1 FN and G in 50 mM Tris-HCI buffer (pH = 7.4). The FN and G were labelled 
with rhodamine (Rh-FN) and fluore~cein isothiocyanate (FITC-G), respectively. c) Fluorescence 
and luminance images of Rh-FN and FITC-G in 1L to 10L- FN-G nanofilm spots. The luminance 
distribution bar is shown at the bottom. d) Dependence of the layer number of the FN- G nanofilm 
spots on the fluorescence intensity (n = 4, over 10 spots per image) . e) Fluorescence merged image 
of "Osaka" letters consisting of the 1L to 5L-FN-G nanofilm spots. f) Thickness of the 10L-FN-G 
nanofilm spots using 0.2 and 0.02 mg ml - 1 solutions before and after 1 hour of incubation in ultrapure 
water (n = 3). The inset shows a photograph of 300 spots from 10L-FN-G nanofilms prepared on a 
slide glass under UV light. 
by this technique showed almost the same drug response as in 
vivo native blood vessels, thus supporting their usefulness for 
drug evaluations as an in vitro blood vessel model. 14) 
In this study, we successfully fabricated 440 micro- arrays of 
simplified human 3D-tissue structures, micrometer-sized 
multilayers with different layer numbers and cell types, using a 
technique combining our hierarchical cell manipulation and 
automatic inkjet printing (Fig. 1) 15) . For high-throughput 
drug evaluations, 3D liver tissue chips, which have high liver 
functions, would be a powerful and important micro- array 
because the liver plays a central role in drug metabolism and 
toxicity. We integrated simplified 3D-liver structures, such as 
monolayered (1L- ) to three- layered (31) structures com-
posed of hepatocytes and endothelial cells, onto a chip. 
Comprehensive high-throughput assays of liver functions 
(albumin secretion, cytochrome-P450 (CYP450) enzyme se-
cretion and CYP450 metabolism activities) were then per-
formed. We found for the first time that these simplified 3D 
liver structures, a sandwich of endothelial cells and hepato-
cytes, revealed the highest functions as compared to other 3D-
structures. Therefore, 3D human tissue chips prepared by this 
rapid and automatic system will be an innovative technology 
for in vitro evaluations of drugs, cosmetics, and chemicals, 
instead of animal testing. 
2. Inkjet printing for LbL nanofilm chips 
We employed a piezo- electronic inkjet printing instrument, 
DeskViewernl (Cluster technology, Osaka, Japan), which has 
four injectors with 25 tlm- sized nozzles, and thus this inkjet 
machine can load and print four kinds of cells or protein 
solutions. The volume and diameter of one drop from the nozzle 
were 17 pi and 32 tlm, respectively. The diameter of the 
obtained inkjet spots was easily controlled by altering the drop 
number; for instance, approximately 65 to 1,950 tlm-sized 
spots were obtained at 1 to 10,000 drop numbers of 0.2 mg/mL 
FN. Stepwise printing of rhodamine labelled-FN (Rh-FN) 
Journal of the Imaging Society of Japan Vol. 51 No.5 (2012) ( 37) 
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Fig.2 a) The printed cell number dependent on the concentration of cell solution (n = 3). b) Cell 
viability of printed C2C12 cells after 20 hours culture (n = 3). c) Relationship between the 
drop number and printed cell number (n = 3) . The concentration of the cell solution was 
1 x 10 7 cells/ mL. The inset shows a phase constrast image of the printed cells at the 1.000 drop 
condition. d) Fluorescence microscopic image of printed C2C12 cells labeled with calcein- AM 
and ethidium homodimer (EthD-1) after 20 hours of incubation. The living and dead cells 
exhibited green and red colors, respectively (Live/ Dead assay) . e) Cell viability of printed 
C2C12, HUVEC, and NHDF cells after 20 hours of culture (n = 3) . f) Hematoxylin and eosin 
(HE), collagen 1. and collagen IV staining histological images of the collected 4L- C2C12 
constructs. 
and fluorescein isothiocyanate labelled-G (FITC-G) was 
performed to fabricate a monolayer (1L) up to ten layers 
(1OL) of 750 .um-sized spots on a slide glass, and subsequently 
these multilayered spots were analyzed by fluorescence 
microscopy (Fig. 1). The color of these spots clearly changed 
depending on the layer number, and the luminescence of Rh-
FN and FITC-G increased in a stepwise manner upon 
increasing the layer number. The fluorescence intensity of Rh-
FN and FITC-G revealed alternate increases upon increasing 
the layer number, and the magnitude of each intensity 
increment was nearly the same value at each step, suggesting a 
homogeneous, step-by-step fabrication of the LbL spots. 
To evaluate the stability of the lOL-FN-G nanofilm spots, the 
thicknesses before and after 1 hour of incubation in ultrapure 
water was investigated using 3D laser scanning microscope. 
When the solution concentrations were 0.2 mg/mL, the mean 
thickness reached over 400 nm, which is approximately 40- fold 
thicker than the results from the quartz crystal microbalance 
(QCM) in our previous reports on the general LbL method, 
including a rinsing step (thickness is ca. 10-15 nm). 10) The 
reason for this was the deposition of excess components (FN, 
G, and ions) due to the exclusion of the rinsing step, and thus 
the remaining thickness after incubation in water decreased 
drastically to about 7 nm due to considerable desorption of the 
components. When we optimized the solution concentration. a 
0.02 mg/mL concentration resulted in reasonable mean thick-
ness (15±7 nm) and high stability, even after 1 hOLlr of 
incubation (11 ±6 nm) . This is the first report of LbL 
nanofilm micro- array spots consisting of proteins fabricated by 
inkjet printing. 
3. Cell printing for multilayered tissue chips 
For the precise control of cellular multilayers, the printing 
cell number should be controlled at the single-cell level. 
Altho ugh some researchers have reported living cell 
printing7-9) from the first report of Wilson and Boland in 2003. 16) 
the optimization of the printing conditions is still important, 
because key factors such as the printed cell number and 
( 38 ) Journal of the Imaging Society of Japan Vol. 51 No.5 (2012) 
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Fig. 3 a) Photograph of 440 micro-well plates and b) 2D or c) 3D scanning images of these micro-
wells by 3D laser scanning microscopy. d) Fluorescence microscopic image focusing on lO x 10 
(100) micro-wells of 2L- NHDF constructs prepared in 440 micro-well plates after 24 hours of 
incubation. The cells were labeled with cell tracker green. e) Fluorescence merged image of 
the 2L - C2C12 constructs focusing on 36 wells (green box), and three layered (3L) constructs 
composed of 1L-HAECI2L-C2C12 in 4 wells (red box) in the same chips after 24 hours of 
incubation. The C2C12 and HAEC cells were labeled with cell tracker green and red, 
respectively. 
viability are significantly influenced by the inkjet instrument. 
Boland et al. reported the effect of the solution concentration of 
E. coli on the printed cell number, and approximately 107 cells/ 
mL is a suitable concentration for single-cell printing without 
any defects. 11) We employed mammalian mouse C2C12 
myoblasts, and evaluated the relationship between the cell 
solution concentration and the printed cell number in detail. 
The 1 x 101 cells/mL concentration provided quantitatively the 
same printed cell number as Boland's report, 17) and a good 
linear correlation was observed from 1 to over 1.000 cells (Fig. 
2). Live/ Dead staining clearly showed considerably high cell 
viability independent of the printed cell number and cell types 
(such as C2C12, human umbilical vein endothelial cells (HU· 
VEC) , or normal human dermal fibroblasts (NHDF». 
To fabricate four layered (4L) structures of micro-tissue 
arrays, we continued the inkjet printing of C2Cl2 myoblasts 
and FN-G for four times in 50-micro-wells as shown in Fig. I. 
accompanied by 24 hours of incubation after each cell printing 
to induce stable cell adhesion. The histological images of 
hematoxylin and eosin (HE) staining obviously revealed 4L-
structures of C2C12 myoblasts, and immunological staining 
with anti-collagen I and IV antibodies demonstrated the 
expression of ECM proteins from the cells of the 4L-micro-
tissues during the culture process. These results clearly 
proved the successful construction of multilayered micro-
tissue arrays by inkjet printing for the first time. 
Hundreds of multilayered micro- tissues integrated into one 
chip are desirable for high-throughput drug evaluation. 
Accordingly, we prepared 440 micro-wells (10 lines X 44 
columns) in a plastic plate, and the diameter and height of 
each well were 500 and 200 tim, respectively (Fig. 3). 
Although the volume of this micro-well is approximately lOO-
fold smaller than that of 96-well plates, cell or protein solutions 
were accurately and quickly printed by our system. Fig. 3d 
shows confocal laser scanning microscopic (CLSM) image of 
100 micro-wells of bilayered (2L) normal human dermal 
fibroblast (NHDF). suggesting the homogeneous fabrication 
of 2L-cellular structures in each micro-well. We also tried to 
fabricate heterocellular multilayers consisting of multiple cell 
types in a specific line of 440 micro-wells. The 2L-constructs of 
C2C12 myoblasts were first prepared by printing, and then one 
more layer of human aortic endothelial cells (HAECs) were 
Journal of the Imaging Society of Japan Vol. 51 No.5' (2012) ( 39 ) 
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Fig.4 a) Photograph of 1L (HepG2 monolayer) , 2L (HUVEC/HepG2) and 3L (HUVEClHepG2/ 
HUVEC) hepatic layered co-culture arrays prepared in 440 micro-well plates under UV light. 
These tissues were immuno fluorescentiy labelled with an anti-human albumin antibody after 48 
hours of incubation. b) The induction of albumin secretion from HepG2 cells in layered co-cultures 
after 2 or 7 days of incubation (n = 3, over 10 wells per image) . The samples were immuno 
fluorescently labelled with an anti-human albumin antibody. c) Fluorescence intensity of CYP3A4 
secretion from HepG2 cells in layered co-cultures after 1 day of incubation (n = 3, over 10 wells per 
image). The samples were immuno fluorescently labelled with an anti-human CYP3A4 antibody. 
d) Fluorescence intensity of the CYP3A4 activity of HepG2 cells in layered co-cultures after 1 day 
of incubation (n = 3, over 10 wells per image). The fluorescence intensity of resorufin, metabolite of 
Vivid red by CYP3A4, was measured in the micro-wells. e) The layer number and dose-
dependent cytotoxicity of troglitazone in co-culture after 2 days of incubation (n = 3, over 10 wells 
per image). The data were normalized to untreated cultures (100% activity). The dead cell 
number was estimated from Live/Dead staining images by the calibration curve. The bottom 
fluorescence images are Live/Dead images of 1L to 3L constructs and HUVEC monolayer at 50 11M 
concentration. The all data in b-d were normalized with blank data (without cells). *, P< 0.05; ** 
P<O.01. N.S. means no significant difference. 
fabricated in the left line. CLSM observation clearly revealed 
multilayered constructs consisting of the two types of cells 
(C2C12 and HAEC) , suggesting the easy control of the layer 
number and cell components at single-well level. 
levels. IS) Co- culture with other cells is a suitable method to 
enhance liver function by the induction of cell-cell interactions, 
but most approaches consist of two-dimensional (2D) co-
culture 4. 19) although actual liver tissue contains hierarchical 
heterocellular constructs with endothelial cells separated by a 
thin ECM layer. We fabricated a liver tissue chip which 
integrated simplified and multilayered 3D-liver structures 
consisting of HepG2 cells and HUVECs because the most 
common cell types in the liver are hepatocytes and endothelial 
cells. 
4. 3D-liver chips for drug evaluation 
Human hepatocellular carcinoma (HepG2) is one of the 
candidate cell lines for the study of human hepatocytes because 
of their reproducible, inexpensive and polarized properties, but 
they display much lower liver-specific functions at abnormal 
( 40 ) Journal of the Imaging Society of Japan Vol. 51 No. 5 (2012) 
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The 1L (HepG2 monolayer) , 2L (HUVEClHepG2), and 3L 
(HUVEC/ HepG2/ HUVEC), were constructed in 440 micro-
well plates to investigate the effect of sandwich cell-cell 
interactions. Theoretically, 3L structures should induce higher 
HepG2 cell activities than 2L structures due to the cell-cell 
interactions at both apical and basal sides, similar to the actual 
liver structure (Fig. 4) . To evaluate the effect of the layer 
number of the' hierarchical co-culture on albumin secretion, 440 
micro- well plates were cultured for 1 week. Albumin secretion 
predictably increased upon increasing the layer number, and a 
4-fold higher secretion was observed from the 3L-sandwiched 
multilayers after 1 week of culture. To assess the utility of 3D 
hepatic tissue micro-arrays for metabolism studies, we 
characterized the phase I CYP450 metabolism activity. The 
secretion of CYP3A4, one of the major CYP450 enzymes in the 
human liver, showed a stepwise increase depending on the 
layer number, and 3L-multilayers showed the highest secre-
tion (2.2- fold higher than that of the 11), as well as the highest 
CYP3A4 activity (2.4-fold higher than that of the 1L). To 
evaluate practical drug metabolism activity, we employed 
t roglitazone (Rezulin ®) the first thiazolidinedione anti- dia-
betic agent approved for clinical use as in 1997, but was 
withdrawn from the market in 2000 by the FDA due to serious 
idiosyncratic hepatotoxicity.2O) Recent toxicological studies 
have revealed that in the human liver, CYP3A4 played a major 
role in the formation of a quinine-type metabolite (M3) from 
troglitazone even at a low concentration and then the further 
metabolized compounds from M3 induced cytotoxicity.2O) Thus, 
troglitazone is currently a good example to evaluate practical 
drug metabolism activity of CYP3A4. Dose-dependent cell 
death was observed, and especially the 3L-multilayers clearly 
showed extensive cell death, even at a low concentration, as 
compared to the 1L and 21. Quantitatively, the estimated IC50 
values (concentration causing 50% cell death) of the 3L-
multilayers reached 43 11M, whereas those of 1L- and 2L-
multilayers were 66 and 60 11M, respectively, suggesting an 
approximately 1.5-fold higher CYP3A4 drug metabolism 
activity in relation to the higher CYP3A4 secretion and 
activity. 
Taken together, our results demonstrate for the first time 
both the development of 3D human tissue chips using a rapid 
and automatic inli:jet printing technique and the successful 
enhancement of the liver functions of HepG2 cells as one of the 
candidates for 3D-human liver chips for drug screenings by 
hierarchical 3L-sandwich structures with HUVECs. 
5. Summary 
In conclusion, rapid and automatic, hierarchical cellmanipu-
lation was successfully performed by a combination of single-
cell printing and the LbL printing of FN-G solutions, and thus 
440 micro-arrays of human tissue constructs consisting of 
multiple cell types were constructed as one chip. This is the 
first report of hundreds of multilayered micro-tissues inte-
grated into one micro- array, and reproduced cell-cell interac-
tions in three- dimensions similar to actual tissues or organs. 
approximately 50-10011m thick (10L-20L) micro-tissue 
arrays containing endothelial tube networks are expected 
using our recently published new method, the cell-accumula-
tion technique, which can induce 3D cell-cell interactions at · 
once and provide thick multilayers during 1 day of 
incubation. 21l Accordingly, this rapid and automatic fabrication 
method of 3D human micro-tissue chips will have great 
potential for tailor-made drug screenings and toxicological 
evaluations instead of animal experiments. 
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